Browsing by Author "Bwakura-Dangarembizi, Mutsa F."
Now showing 1 - 1 of 1
Results Per Page
Sort Options
Item Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial(The Lancet HIV, 2022-07-19) Turkova, Anna; Bwakura-Dangarembizi, Mutsa F.; Kekitiinwa, Adeodata R.; Lugemwa, Abbas; Ahimbisibwe, Grace Miriam; Burger, David M.Children with HIV-associated tuberculosis (TB) have few antiretroviral therapy (ART) options. We aimed to evaluate the safety and pharmacokinetics of dolutegravir twice-daily dosing in children receiving rifampicin for HIV-associated TB.